Health in Tech (HIT): Chief Growth Officer had shares withheld for tax 3,448 shares
Zain Syed Hasan, Chief Growth Officer at Health in Tech, reported a tax withholding of 3,448 shares.
- 3,448
- Shares · @ $1.50
- Traded
- Apr 15, 2026
- Filed
- Apr 17, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Mar 25, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
- Mar 25, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
- Mar 27, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
What came next
- Apr 27, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“Following receipt of formal notice on April 27, 2026, Dustin Plantholt departed from his role as Chief AI & Marketing Officer of Health In Tech, Inc. (the “Company”), effective as of April 30, 2026, as part of a business transition and not as a result of any disagreement with the Company on any matter relating to its operations, policies or practices.”
- May 13, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
- Aug 13, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Health in Tech
For Health in Tech, OQRO holds 6 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HIT page.
Other recent filings by Zain Syed Hasan, Chief Growth Officer
- SEC Form 4 at Health in Tech (HIT)Nov 5, 2026
- SEC Form 4 at Health in Tech (HIT)Oct 19, 2026
- SEC Form 4 at Health in Tech (HIT)Sep 14, 2026
The full history of Zain Syed Hasan, Chief Growth Officer is on the profile page.
How this filing works
Explore the data
Common questions
Which Health in Tech (HIT) insider traded, and how much?
Zain Syed Hasan, Chief Growth Officer at Health in Tech, reported a tax withholding of 3,448 shares. At $1.50.
When did it happen, and when was it made public?
Traded: Apr 15, 2026. Filed: Apr 17, 2026. That is 2 days between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Health in Tech recently?
For Health in Tech, OQRO holds 6 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the HIT page.
Does this mean HIT stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Health in Tech
- SEC Form 4Nov 5, 2026
- SEC Form 4Oct 19, 2026
- SEC Form 4Sep 15, 2026
- SEC Form 4Sep 14, 2026
- SEC Form 4Sep 12, 2026
- SEC Form 4Sep 12, 2026
Everything OQRO holds on this company is on its HIT page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
